title: A multicenter analysis of "time to microcatheter" for endovascular therapy in acute ischemic stroke.
abstract: OBJECTIVE
  At present, no time recommendation for initiation of endovascular treatment in acute ischemic stroke is available. A multicenter analysis was designed to identify variables that prolong "time to microcatheter," defined as the time interval from computed tomographic scan to microcatheter placement in the cerebral circulation.
  
  
  METHODS
  Consecutive acute ischemic stroke patients from 3 academic stroke centers were included. Analysis of covariance was used to evaluate different variables that prolong "time to microcatheter."
  
  
  RESULTS
  Ninety-one patients underwent emergent endovascular treatment for acute ischemic stroke. Mean "time to microcatheter" was 174±60 minutes. No significant time difference was found in patients who were intubated, presented at night or weekends, were administered intravenous recombinant tissue plasminogen activator, or underwent additional imaging prior to endovascular treatment. "Time to microcatheter" was significantly longer in nonlevel I trauma centers and in patients with National Institutes of Health Stroke Scale Score of 10 to 19.
  
  
  CONCLUSIONS
  Wide variability of "time to microcatheter" among institutions highlights the need for standardized time goals.
authors.affiliation: Zeenat Qureshi Stroke Research Center, Department of Neurology, University of Minnesota, Minneapolis, MN 55455, USA. miley011@umn.edu
authors.forename: Jefferson T
authors.initials: JT
authors.lastname: Miley
authors.forename: Muhammad Zeeshan
authors.initials: MZ
authors.lastname: Memon
authors.forename: Haitham M
authors.initials: HM
authors.lastname: Hussein
authors.forename: Douglas A
authors.initials: DA
authors.lastname: Valenta
authors.forename: M Fareed K
authors.initials: MF
authors.lastname: Suri
authors.forename: Gabriela
authors.initials: G
authors.lastname: Vazquez
authors.forename: Adnan I
authors.initials: AI
authors.lastname: Qureshi
mesh_terms: D000368:Aged; D000704:Analysis of Variance; D002404:Catheterization / Q000379:methods*; D002533:Cerebral Angiography; D015897:Comorbidity; D003287:Contrast Media / Q000008:administration & dosage; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D018579:Patient Selection; D020521:Stroke / Q000000981:diagnostic imaging / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D003287:Contrast Media; D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator